In this issue:
Associations between myeloid neoplasia and second primary cancer
Leukaemia and myeloid malignancy after low-dose radiation exposure
Deferoxamine chelation vs. no therapy in nontransfusion-dependent thalassaemia
Effects of thalidomide on haemoglobin synthesis in thalassaemia intermedia
Haploidentical HSCT with FBCA conditioning in thalassaemia major
Ruxolitinib for inadequately controlled polycythaemia vera without splenomegaly
Imatinib-based chemotherapy for Ph+ ALL
Rituximab-containing regimens in idiopathic multicentric Castleman’s disease
Cancer-associated thrombosis in patients with implanted ports
Please login below to download this issue (PDF)